Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: 1. men, and women, over 18 years of age inclusively. 2. patient is suspected to have covid-19 infection. 3. provides consent or consent is given by their legally authorized representative (lar). 4. agrees to the collection of venous blood per protocol. 5. women of childbearing potential (wocbp) and men (if their sexual partners are wocbp) must use at least 1 highly effective form of birth control throughout the study and for 6 months after the last dose of study treatment. highly effective methods of birth control include true sexual abstinence (defined as refraining from heterosexual intercourse during the entire period of risk, in line with the preferred and usual lifestyle of the patient), surgery (bilateral tubal ligation or occlusion, vasectomized partner), progestogen-only or estrogen/progestogen hormonal contraceptive associated with inhibition of ovulation (oral, patch, injectable, implantable, or intravaginal), intrauterine device (iud), or intrauterine hormone-releasing system (ius).

inclusion criteria: 1. men, and women, over 18 years of age inclusively. 2. patient is suspected to have covid-19 infection. 3. provides consent or consent is given by their legally authorized representative (lar). 4. agrees to the collection of venous blood per protocol. 5. women of childbearing potential (wocbp) and men (if their sexual partners are wocbp) must use at least 1 highly effective form of birth control throughout the study and for 6 months after the last dose of study treatment. highly effective methods of birth control include true sexual abstinence (defined as refraining from heterosexual intercourse during the entire period of risk, in line with the preferred and usual lifestyle of the patient), surgery (bilateral tubal ligation or occlusion, vasectomized partner), progestogen-only or estrogen/progestogen hormonal contraceptive associated with inhibition of ovulation (oral, patch, injectable, implantable, or intravaginal), intrauterine device (iud), or intrauterine hormone-releasing system (ius).

July 27, 2023, 4 a.m. usa

inclusion criteria: men, and women, over 18 years of age inclusively. patient is suspected to have covid-19 infection. provides consent or consent is given by their legally authorized representative (lar). agrees to the collection of venous blood per protocol. women of childbearing potential (wocbp) and men (if their sexual partners are wocbp) must use at least 1 highly effective form of birth control throughout the study and for 6 months after the last dose of study treatment. highly effective methods of birth control include true sexual abstinence (defined as refraining from heterosexual intercourse during the entire period of risk, in line with the preferred and usual lifestyle of the patient), surgery (bilateral tubal ligation or occlusion, vasectomized partner), progestogen-only or estrogen/progestogen hormonal contraceptive associated with inhibition of ovulation (oral, patch, injectable, implantable, or intravaginal), intrauterine device (iud), or intrauterine hormone-releasing system (ius).

inclusion criteria: men, and women, over 18 years of age inclusively. patient is suspected to have covid-19 infection. provides consent or consent is given by their legally authorized representative (lar). agrees to the collection of venous blood per protocol. women of childbearing potential (wocbp) and men (if their sexual partners are wocbp) must use at least 1 highly effective form of birth control throughout the study and for 6 months after the last dose of study treatment. highly effective methods of birth control include true sexual abstinence (defined as refraining from heterosexual intercourse during the entire period of risk, in line with the preferred and usual lifestyle of the patient), surgery (bilateral tubal ligation or occlusion, vasectomized partner), progestogen-only or estrogen/progestogen hormonal contraceptive associated with inhibition of ovulation (oral, patch, injectable, implantable, or intravaginal), intrauterine device (iud), or intrauterine hormone-releasing system (ius).

Oct. 26, 2020, 11:31 p.m. usa

inclusion criteria: - men, and women, over 18 years of age inclusively - patient is hospitalized due to suspected covid-19 infection - agrees to the collection of venous blood per protocol

inclusion criteria: - men, and women, over 18 years of age inclusively - patient is hospitalized due to suspected covid-19 infection - agrees to the collection of venous blood per protocol